SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041607
Filing Date
2023-08-11
Accepted
2023-08-11 07:31:32
Documents
49
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q hcwb-20230630.htm   iXBRL 10-Q 1686506
2 EX-31.1 hcwb-ex31_1.htm EX-31.1 18195
3 EX-31.2 hcwb-ex31_2.htm EX-31.2 18352
4 EX-32.1 hcwb-ex32_1.htm EX-32.1 12687
5 EX-32.2 hcwb-ex32_2.htm EX-32.2 12351
  Complete submission text file 0000950170-23-041607.txt   4945894

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hcwb-20230630_lab.xml EX-101.LAB 264482
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hcwb-20230630_cal.xml EX-101.CAL 27918
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hcwb-20230630.xsd EX-101.SCH 28357
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hcwb-20230630_pre.xml EX-101.PRE 191217
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hcwb-20230630_def.xml EX-101.DEF 126909
43 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20230630_htm.xml XML 668014
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

IRS No.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40591 | Film No.: 231161533
SIC: 2834 Pharmaceutical Preparations